Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Is German Digital Health Care Act an under-used failure?  

In 2019, Germay passed a new law designed to revolutionize the e-health market by reimbursing therapeutic apps. Why hasn't it had more of an impact? HBI speaks with Sven Jungmann, Chief Medical Officer in Berlin-based corporate venture builderFoundersLane, to find out.

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.

Investors choose between Affidea and IVI RMA

Big private equity players in health care face a choice as to whether to go for Pan-European imaging group Affidea which is for sale through Goldman Sachs or for IVI RMA, the international fertility group.

UK self-pay “almost doubles” to a potential 15m

The self-pay market in the UK is growing much faster than other parts of the private sector. Justin Ash, CEO of the UK’s second largest for-profit hospital group, Spire Healthcare, tells us it almost doubled to 15m people in the past two years, and will only continue to grow in the face of the NHS backlog.

Residential care costs of dementia care soar

Alzheimer’s is one of the world’s most expensive diseases, costing around $1 trillion per year globally, research estimates. As cases are forecast to triple by 2050, this figure is only going to increase. To make matters worse, new research suggests that the per-person cost of treatment is also growing.

Orpea and Korian’s share prices boosted by hidden camera exposé

Both Korian and Orpea’s share prices increased more than 10% after the release of investigative TV show Cash Investigation’s hidden camera episode revealing scenes inside a Korian nursing home. Meanwhile Orpea’s expansion into Russia has been halted after last week’s invasion of Ukraine and French public investment bank Bpifrance pulled out. 

Korian launches transformation into ‘mission-led’ company

French elderly care giant Korian is having to walk a fine line between reporting a return to strong revenue and earnings growth in 2021 whilst simultaneously affirming its commitment to always putting the welfare of its residents and quality of care first. The approach it has adopted is to herald the launch of a new strategy: to become a ‘mission-led’ company!  Meanwhile Orpea has postponed its annual results until at last as April 30. 

Find Us